Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The firm offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma; and Glider PTCA for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries; Chocolate Touch, a drug-coated balloon catheter; GliderfleX PTA for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.
Singapore, 609935, Singapore